Paclitaxel-Based Chemotherapy Targeting Cancer Stem Cells from Mono- to Combination Therapy.

Nawara, Hend M; Afify, Said M; Hassan, Ghmkin; Zahra, Maram H; Seno, Akimasa; Seno, Masaharu

Nawara, Hend M; Afify, Said M; Hassan, Ghmkin; Zahra, Maram H; Seno, Akimasa; Seno, Masaharu.

Afiliación

Nawara HM; Department of Biotechnology and Drug Discovery, Graduate School of Interdisciplinary Science and Engineering in Health Systems, Okayama University, Okayama 700-8530, Japan.
Afify SM; Department of Biotechnology and Drug Discovery, Graduate School of Interdisciplinary Science and Engineering in Health Systems, Okayama University, Okayama 700-8530, Japan.
Hassan G; Division of Biochemistry, Chemistry Department, Faculty of Science, Menoufia University, Menoufia 32511, Egypt.
Zahra MH; Department of Biotechnology and Drug Discovery, Graduate School of Interdisciplinary Science and Engineering in Health Systems, Okayama University, Okayama 700-8530, Japan.
Seno A; Department of Microbiology and Biochemistry, Faculty of Pharmacy, Damascus University, Damascus 10769, Syria.
Seno M; Department of Biotechnology and Drug Discovery, Graduate School of Interdisciplinary Science and Engineering in Health Systems, Okayama University, Okayama 700-8530, Japan.

Biomedicines ; 9(5)2021 May 02.

Article en En | MEDLINE | ID: mdl-34063205

Palabras clave

anticancer; cancer stem cells; combination therapy; microtubule targeting agent; paclitaxel

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Biomedicines Año: 2021 Tipo del documento: Article País de afiliación: Japón

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google